← Back to headlines
Novo Nordisk Expects Generic Ozempic Delay in China Until Next Year
Novo Nordisk anticipates that the availability of generic versions of its popular diabetes drug, Ozempic, in China will be delayed until next year.
6 May, 11:20 — 6 May, 11:20
Sources
Showing 1 of 1 sources
